Developer of a cell medicine designed to repair intractable diseases and tissue damage. The company's medicine utilizes serum-free, mesenchymal stromal cells derived from umbilical cords, featuring ad...

Healthcare
Tokyo, Japan
Founded 2017
50 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$30.4M
Last Round
N/A

Get the full picture

Create a free account to unlock Human Life CORD's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required